Marco Della Peruta

Title: Marco Della Peruta: Innovator in Cancer Treatment

Introduction

Marco Della Peruta is a prominent inventor based in London, GB. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, Della Peruta is recognized for his work in developing advanced therapeutic techniques.

Latest Patents

One of his latest patents is focused on ROR1 CAR T-cells. This patent describes a chimeric antigen receptor (CAR) that includes an antigen binding domain which selectively binds to Receptor Tyrosine Kinase Like Orphan Receptor 1 (ROR1). The patent outlines the use of this CAR in T cells for the treatment of cancer. Another notable patent involves ROR1 antibodies, which specifically bind to a ROR1 polypeptide. This patent details the use of isolated monoclonal antibodies in various applications, including the detection, prevention, and treatment of cancer.

Career Highlights

Marco Della Peruta has established himself as a key figure in the field of cancer research. His innovative approaches have garnered attention and respect within the scientific community. He is associated with UCL Business Plc, where he continues to advance his research and development efforts.

Collaborations

Della Peruta has collaborated with notable professionals in his field, including Amit Nathwani and Satyen Gohil. These collaborations have further enhanced his research and contributed to the development of groundbreaking therapies.

Conclusion

Marco Della Peruta is a distinguished inventor whose work in cancer treatment is paving the way for innovative therapies. His patents reflect a commitment to advancing medical science and improving patient outcomes.